Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 385 followers
Latest posts
Last updated 2 days ago
9 pharma giants reach US drug price deals with Trump administration
2 days ago
Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Gilead, GSK, Merck & Co., Novartis...
AstraZeneca to pull bleeding reversal agent Andexxa after FDA flags risk imbalance
2 days ago
After a series of ownership changes, Andexxa is slated to be pulled...
FDA outlined concerns with Elevidys manufacturing at Catalent site, Form 483 shows
2 days ago
The Elevidys-related manufacturing shortfalls were described in one of two Form 483s...
BioMarin makes largest-ever transaction, paying $4.8B for fellow rare disease drugmaker Amicus
2 days ago
Sixteen months after luring former Roche dealmaker James Sabry, M.D., Ph.D., out...
BMS’ Cobenfy TV ad is latest target of FDA untitled letter spree
2 days ago
As the FDA steadily churns out a stream of untitled letters chastising...
Partners Alvotech, Teva eye 2026 Eylea biosimilar launch in US with Regeneron settlement
2 days ago
Alvotech and Teva's Eylea biosimilar has been under FDA review for much...
Cybin alters state to become Helus Pharma for Nasdaq trip
2 days ago
Cybin is shedding its old identity, evolving into Helus Pharma as part...
A year in review and what 2026 holds for biopharma and healthcare
2 days ago
Fierce reporters break down the forces that shaped biopharma and healthcare in...
2026 forecast: Pharma clicks with patients as direct sales model shifts marketing strategies
2 days ago
Pharma marketers enter 2026 asking where DTC fits in the DTP era...
2026 forecast: Pharma ad dollars will continue shifting away from traditional TV
3 days ago
Amid rapidly evolving media consumption habits and a federal push to limit...
Fierce Pharma Asia—Daiichi ADCs' 1st-line nod, trial deaths; Takeda's TYK2 trial win
3 days ago
Daiichi Sankyo scored a key FDA approval for Enhertu in first-line HER2-positive...
Medtronic encourages people with Type 1 diabetes to ‘Own It’ in new MiniMed campaign
3 days ago
As Medtronic begins rolling out a recently FDA-cleared diabetes management system combining...